← Back to Clinical Trials
Recruiting NCT06846177

NCT06846177 Graded Activity Training and Task- Oriented Training on Post-Stroke Fatigue

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06846177
Status Recruiting
Phase
Sponsor Riphah International University
Condition Post-Stroke Fatigue
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2025-03-01
Primary Completion 2026-03-20

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
Graded Activity TrainingTask-Oriented Training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2025-03-01 with a primary completion date of 2026-03-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this randomized controlled trial is to determine the effects of Graded Activity Training and Task Oriented Training on Fatigue in Post-Stroke Patients. Until now there is very limited work found on fatigue so this will increase quality of life in stroke patients and potentially reduce burden on healthcare system.

Eligibility Criteria

Inclusion Criteria: * Both male and female of age 40 to 60 years. * Patient with both ischemic or hemorrhagic stroke. * Patient with both right and left hemiplegia. * Checklist Individual (CIS-F) fatigue score of 40 or more. * Patients who had sustained a stroke more than 4 months before recruitment. * Patients who can independently walk for 10 meters (about 33 feets) Exclusion Criteria: * Patients with severe comorbid health conditions (such as cardiac diseases, pulmonary diseases like COPD, Orthopedic Conditions Arthritis, joint replacements). * Patients with uncontrolled diabetes, hypertension, Depression and Anxiety. * Patients who are not willing to participate. * Patient with any medications that can affect their ability to engage in physical training program like Antidepressants, Beta-Blockers, corticosteroids etc. * Pregnant women.

Contact & Investigator

Central Contact

Dr.Aroosa Tariq, MS-NMPT

✉ aroosa.tariq@riphah.edu.pk

📞 03161578156

Principal Investigator

Dr.Aroosa Tariq, MS-NMPT

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT06846177 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 60 Years, studying Post-Stroke Fatigue. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06846177 currently recruiting?

Yes, NCT06846177 is actively recruiting participants. Contact the research team at aroosa.tariq@riphah.edu.pk for enrollment information.

Where is the NCT06846177 trial being conducted?

This trial is being conducted at Mansehra, Pakistan.

Who is sponsoring the NCT06846177 clinical trial?

NCT06846177 is sponsored by Riphah International University. The principal investigator is Dr.Aroosa Tariq, MS-NMPT at Riphah International University. The trial plans to enroll 20 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology